OR WAIT null SECS
September 03, 2019
A global agreement with Polpharma Biologics gives Sandoz commercialization rights to a proposed biosimilar natalizumab for relapsing-remitting multiple sclerosis.
August 27, 2019
A ruling in Oklahoma that Johnson & Johnson’s marketing efforts created a public nuisance may establish a precedent of other jurisdictions.
August 26, 2019
The transaction is part of Bristol-Myers Squibb’s proposed acquisition of Celgene.
August 21, 2019
Pfizer is investing $500 million for the construction of a state-of-the-art gene therapy manufacturing facility in Sanford, NC.
August 12, 2019
Jack Bailey, president, US Pharmaceuticals, GlaxoSmithKline, will step down from his position at the end of 2019 and will be succeeded by a Merck KGaA executive.
August 09, 2019
The facility will support gene therapy production and continued development of PTC’s pipeline of investigational medicines.
August 08, 2019
South Korea’s pharma/biotech space is projected to grow to $23.2 billion by 2022, and will likely attract foreign investment, according to a new market report by GlobalData.
August 02, 2019
Fifty years after the man walked on the Moon, space-based science is benefiting Earth.
August 01, 2019
Biopharma industry faces production challenges as gene therapies move from clinical to commercialization.
Mass-produce cell and gene therapies presents the biopharma industry with a unique set of challenges.